Current Assets

Marketable Equity Securities (FV-NI) - Cost Basis

MetLife Marketable Equity Securities (FV-NI) - Cost Basis decreased by 0.7% to $10.61B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 23.9%, from $8.57B to $10.61B. Over 4 years (FY 2021 to FY 2025), Marketable Equity Securities (FV-NI) - Cost Basis shows relatively stable performance with a 2.0% CAGR.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2025
Last reportedQ1 2026
Metric ID: marketable_equity_securities_fv_ni_cost

Historical Data

18 periods
 Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$9.89B$9.77B$9.16B$8.68B$9.11B$9.18B$9.08B$8.67B$8.74B$8.30B$8.01B$7.29B$8.28B$8.57B$9.00B$9.08B$10.69B$10.61B
QoQ Change—-1.2%-6.2%-5.3%+4.9%+0.9%-1.1%-4.6%+0.9%-5.1%-3.4%-9.0%+13.7%+3.4%+5.1%+0.9%+17.7%-0.7%
YoY Change————-7.9%-6.0%-0.9%-0.1%-4.0%-9.7%-11.8%-15.9%-5.2%+3.3%+12.3%+24.6%+29.0%+23.9%
Range$7.29B – $10.69B
CAGR+1.7%
Avg YoY Growth+2.2%
Median YoY Growth-2.4%

Frequently Asked Questions

What is MetLife's marketable equity securities (fv-ni) - cost basis?
MetLife (MET) reported marketable equity securities (fv-ni) - cost basis of $10.61B in Q1 2026.
How has MetLife's marketable equity securities (fv-ni) - cost basis changed year-over-year?
MetLife's marketable equity securities (fv-ni) - cost basis increased by 23.9% year-over-year, from $8.57B to $10.61B.
What is the long-term trend for MetLife's marketable equity securities (fv-ni) - cost basis?
Over 4 years (2021 to 2025), MetLife's marketable equity securities (fv-ni) - cost basis has grown at a 2.0% compound annual growth rate (CAGR), from $9.89B to $10.69B.